Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting

Indian Heart J. 2022 May-Jun;74(3):245-248. doi: 10.1016/j.ihj.2022.03.008. Epub 2022 Mar 25.

Abstract

A cross-sectional study was conducted to predict time in therapeutic range (TTR) using clinical history, examination, and socioeconomic data. Study included warfarin-receiving patients from outpatient-clinic. In 203 patients studied, mean warfarin start-dose was 2.55 mg/day and maintenance-dose/week was 30.79 mg. Body mass index (BMI) (p = 0.03), warfarin maintenance dose/day (p = 0.02), and comorbidity presence (p = 0.04) were significantly associated with TTR. Occupation (p = 0.53), income (p = 0.83), education (p = 0.55), and socioeconomic score (p = 0.73) showed non-significant association with TTR. A TTR predicting nomogram was built from clinical history and examination findings.

Keywords: INR; Percent time in therapeutic range; Warfarin nomogram.

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / complications
  • Cost-Benefit Analysis
  • Cross-Sectional Studies
  • Humans
  • International Normalized Ratio
  • Nomograms
  • Warfarin* / therapeutic use

Substances

  • Anticoagulants
  • Warfarin